{"slug":"rare-cancers","tag":"rare-cancers","variants":["rare-cancers"],"description":"No description yet","count":5,"kinds":{"person":5},"related":[{"slug":"sarcoma","tag":"sarcoma","shared":3},{"slug":"trialist","tag":"trialist","shared":3},{"slug":"brain","tag":"brain","shared":1},{"slug":"immunotherapy","tag":"immunotherapy","shared":1},{"slug":"italy","tag":"italy","shared":1},{"slug":"targeted-therapy","tag":"targeted-therapy","shared":1},{"slug":"uveal-melanoma","tag":"uveal-melanoma","shared":1}],"records":[{"id":"richard-carvajal","kind":"person","name":"Richard D. Carvajal","route":"/people/richard-carvajal/","tldr":"Melanoma oncologist who led the tebentafusp programme in the United States and defined targeted therapy for rare melanoma subtypes."},{"id":"silvia-stacchiotti","kind":"person","name":"Silvia Stacchiotti","route":"/people/silvia-stacchiotti/","tldr":"Italian oncologist who leads histology-specific trials in ultra-rare sarcomas and the Connective Tissue Oncology Society."},{"id":"scott-plotkin","kind":"person","name":"Scott R. Plotkin","route":"/people/scott-plotkin/","tldr":"Boston neuro-oncologist who showed that bevacizumab can shrink vestibular schwannomas and restore hearing in people with neurofibromatosis type 2."},{"id":"andrew-wagner","kind":"person","name":"Andrew J. Wagner","route":"/people/andrew-wagner/","tldr":"Boston sarcoma doctor who first showed that mTOR inhibitors shrink perivascular epithelioid cell tumours and then led AMPECT, the trial that made nab-sirolimus the first approved treatment for these rare cancers."},{"id":"alice-chen","kind":"person","name":"Alice P. Chen","route":"/people/alice-chen/","tldr":"NCI oncologist who led the trial that showed atezolizumab produces lasting responses in alveolar soft part sarcoma, the first approved treatment for this rare cancer."}]}